Milestone® Biotechnologies announced that it has raised over CNY 100 million in a round of funding led by new investor, Weifang Zhongke Haichuang Equity Investment Partnership Enterprise (Limited Partnership), a fund managed by Haichuang Tiancheng (Guangzhou) Equity Investment Fund Management Co., Ltd., an investment arm on August 22, 2023. The transaction also included participation from new investors, Jiangsu Addor Equity Investment Fund Management Co., Ltd., GL Ventures, Shanghai Titan Scientific Co., Ltd. and Jiaxing Tongyu Private Equity Fund Management Co., Ltd.